Does the microbiota play a role in the pathogenesis of autoimmune diseases?

Mairi Hall McLean*, Dario Dieguez, Lindsey M. Miller, Howard A. Young

*Corresponding author for this work

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

The microbiota of the human metaorganism is not a mere bystander. These microbes have coevolved with us and are pivotal to normal development and homoeostasis. Dysbiosis of the GI microbiota is associated with many disease susceptibilities, including obesity, malignancy, liver disease and GI pathology such as IBD. It is clear that there is direct and indirect crosstalk between this microbial community and host immune response. However, the precise mechanism of this microbial influence in disease pathogenesis remains elusive and is now a major research focus. There is emerging literature on the role of the microbiota in the pathogenesis of autoimmune disease, with clear and increasing evidence that changes in the microbiota are associated with some of these diseases. Examples include type 1 diabetes, coeliac disease and rheumatoid arthritis, and these contribute significantly to global morbidity and mortality. Understanding the role of the microbiota in autoimmune diseases may offer novel insight into factors that initiate and drive disease progression, stratify patient risk for complications and ultimately deliver new therapeutic strategies. This review summarises the current status on the role of the microbiota in autoimmune diseases.

Original languageEnglish
Pages (from-to)332-341
Number of pages10
JournalGut
Volume64
Issue number2
Early online date28 Nov 2014
DOIs
Publication statusPublished - 8 Aug 2015

Fingerprint

Microbiota
Autoimmune Diseases
Dysbiosis
Disease Susceptibility
Celiac Disease
Type 1 Diabetes Mellitus
Disease Progression
Liver Diseases
Rheumatoid Arthritis
Homeostasis
Obesity
Pathology
Morbidity
Mortality
Research
Neoplasms

Keywords

  • Autoimmune Diseases
  • Microbiota
  • Pathogenesis

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Does the microbiota play a role in the pathogenesis of autoimmune diseases? / McLean, Mairi Hall; Dieguez, Dario; Miller, Lindsey M.; Young, Howard A.

In: Gut, Vol. 64, No. 2, 08.08.2015, p. 332-341.

Research output: Contribution to journalArticle

McLean, Mairi Hall ; Dieguez, Dario ; Miller, Lindsey M. ; Young, Howard A. / Does the microbiota play a role in the pathogenesis of autoimmune diseases?. In: Gut. 2015 ; Vol. 64, No. 2. pp. 332-341.
@article{73976dcf940b41579d669d2bb7b7da40,
title = "Does the microbiota play a role in the pathogenesis of autoimmune diseases?",
abstract = "The microbiota of the human metaorganism is not a mere bystander. These microbes have coevolved with us and are pivotal to normal development and homoeostasis. Dysbiosis of the GI microbiota is associated with many disease susceptibilities, including obesity, malignancy, liver disease and GI pathology such as IBD. It is clear that there is direct and indirect crosstalk between this microbial community and host immune response. However, the precise mechanism of this microbial influence in disease pathogenesis remains elusive and is now a major research focus. There is emerging literature on the role of the microbiota in the pathogenesis of autoimmune disease, with clear and increasing evidence that changes in the microbiota are associated with some of these diseases. Examples include type 1 diabetes, coeliac disease and rheumatoid arthritis, and these contribute significantly to global morbidity and mortality. Understanding the role of the microbiota in autoimmune diseases may offer novel insight into factors that initiate and drive disease progression, stratify patient risk for complications and ultimately deliver new therapeutic strategies. This review summarises the current status on the role of the microbiota in autoimmune diseases.",
keywords = "Autoimmune Diseases, Microbiota, Pathogenesis",
author = "McLean, {Mairi Hall} and Dario Dieguez and Miller, {Lindsey M.} and Young, {Howard A.}",
year = "2015",
month = "8",
day = "8",
doi = "10.1136/gutjnl-2014-308514",
language = "English",
volume = "64",
pages = "332--341",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Does the microbiota play a role in the pathogenesis of autoimmune diseases?

AU - McLean, Mairi Hall

AU - Dieguez, Dario

AU - Miller, Lindsey M.

AU - Young, Howard A.

PY - 2015/8/8

Y1 - 2015/8/8

N2 - The microbiota of the human metaorganism is not a mere bystander. These microbes have coevolved with us and are pivotal to normal development and homoeostasis. Dysbiosis of the GI microbiota is associated with many disease susceptibilities, including obesity, malignancy, liver disease and GI pathology such as IBD. It is clear that there is direct and indirect crosstalk between this microbial community and host immune response. However, the precise mechanism of this microbial influence in disease pathogenesis remains elusive and is now a major research focus. There is emerging literature on the role of the microbiota in the pathogenesis of autoimmune disease, with clear and increasing evidence that changes in the microbiota are associated with some of these diseases. Examples include type 1 diabetes, coeliac disease and rheumatoid arthritis, and these contribute significantly to global morbidity and mortality. Understanding the role of the microbiota in autoimmune diseases may offer novel insight into factors that initiate and drive disease progression, stratify patient risk for complications and ultimately deliver new therapeutic strategies. This review summarises the current status on the role of the microbiota in autoimmune diseases.

AB - The microbiota of the human metaorganism is not a mere bystander. These microbes have coevolved with us and are pivotal to normal development and homoeostasis. Dysbiosis of the GI microbiota is associated with many disease susceptibilities, including obesity, malignancy, liver disease and GI pathology such as IBD. It is clear that there is direct and indirect crosstalk between this microbial community and host immune response. However, the precise mechanism of this microbial influence in disease pathogenesis remains elusive and is now a major research focus. There is emerging literature on the role of the microbiota in the pathogenesis of autoimmune disease, with clear and increasing evidence that changes in the microbiota are associated with some of these diseases. Examples include type 1 diabetes, coeliac disease and rheumatoid arthritis, and these contribute significantly to global morbidity and mortality. Understanding the role of the microbiota in autoimmune diseases may offer novel insight into factors that initiate and drive disease progression, stratify patient risk for complications and ultimately deliver new therapeutic strategies. This review summarises the current status on the role of the microbiota in autoimmune diseases.

KW - Autoimmune Diseases

KW - Microbiota

KW - Pathogenesis

UR - http://www.scopus.com/inward/record.url?scp=84920971304&partnerID=8YFLogxK

U2 - 10.1136/gutjnl-2014-308514

DO - 10.1136/gutjnl-2014-308514

M3 - Article

VL - 64

SP - 332

EP - 341

JO - Gut

JF - Gut

SN - 0017-5749

IS - 2

ER -